JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.38 Cr | ₹-0.01 Cr | ₹0.29 Cr | ₹0.49 Cr | ₹0.08 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.38 Cr |
| Mar2024 | ₹-0.01 Cr |
| Mar2023 | ₹0.29 Cr |
| Mar2022 | ₹0.49 Cr |
| Mar2021 | ₹0.08 Cr |
How is Deferred Tax Assets / Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.38 Cr | Negative | |
| Mar2024 | ₹-0.01 Cr | Negative | |
| Mar2023 | ₹0.29 Cr | -39.59 | |
| Mar2022 | ₹0.49 Cr | 484.34 | |
| Mar2021 | ₹0.08 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹444.7 Cr | -4.6% | 1.1% | 1.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -4.6% |
1.1% |
1.6% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses